Insulatard Evrópusambandið - íslenska - EMA (European Medicines Agency)

insulatard

novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.

Liprolog Evrópusambandið - íslenska - EMA (European Medicines Agency)

liprolog

eli lilly nederland b.v. - insúlín lispró - sykursýki - lyf notuð við sykursýki - fyrir meðferð fullorðna og börn með sykursýki sem þurfa insúlín til að viðhalda eðlilegt glúkósa homeostasis. liprolog er einnig ætlað til upphafs stöðugleika sykursýki.

Mixtard Evrópusambandið - íslenska - EMA (European Medicines Agency)

mixtard

novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.

Protaphane Evrópusambandið - íslenska - EMA (European Medicines Agency)

protaphane

novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.

Celdoxome pegylated liposomal Evrópusambandið - íslenska - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doxórúbicín hýdróklóríð - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - Æxlishemjandi lyf - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Metvix Krem 160 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metvix krem 160 mg/g

galderma nordic ab - methyl aminolevulinate hydrochloride - krem - 160 mg/g

Humulin NPH KwikPen Stungulyf, dreifa í áfylltum lyfjapenna 100 a.e./ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

humulin nph kwikpen stungulyf, dreifa í áfylltum lyfjapenna 100 a.e./ml

eli lilly danmark a/s - insulin human - stungulyf, dreifa í áfylltum lyfjapenna - 100 a.e./ml

Geepenil Vet. Stungulyfsstofn og leysir, lausn 24 g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

geepenil vet. stungulyfsstofn og leysir, lausn 24 g

orion corporation - benzylpenicillinum natríum - stungulyfsstofn og leysir, lausn - 24 g

Sevelamerkarbonat WH Filmuhúðuð tafla 800 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sevelamerkarbonat wh filmuhúðuð tafla 800 mg

williams & halls ehf - sevelamerum karbónat - filmuhúðuð tafla - 800 mg

Vaminolac Innrennslislyf, lausn Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vaminolac innrennslislyf, lausn

fresenius kabi ab - histidinum inn; phenylalaninum inn; leucinum inn; tyrosinum inn; serinum inn; lysinum inn; cysteinum inn; glycinum inn; prolinum inn; tryptophanum inn; methioninum inn; threoninum inn; isoleucinum inn; taurinum inn; acidum glutamicum inn; valinum inn; argininum inn; acidum asparticum inn; alaninum inn - innrennslislyf, lausn